The molecular basis for psychosocial-distress mediated immune-dysregulation is not well understood. The purpose of this study was to determine whether peripheral blood mononuclear cell (PBMC) epigenetic pattern associates with this form of immune dysregulation. Women newly diagnosed with early stage breast cancer were enrolled into the study and psychosocial, immunological and epigenetic assessments were made at diagnosis and four months later, after completion of cancer treatment. At diagnosis women reported increased perceived stress, anxiety, and mood disturbance and the PBMC of these women exhibited reduced natural killer cell activity and reduced production of interferon gamma, which contrasted with results, obtained after completion of treatment. At the epigenetic level, a PBMC subset derived from women at diagnosis exhibited a distinct epigenetic pattern, with reduced nuclear acetylation of histone residues H4-K8 and H4-K12, as well as reduced phosphorylation of H3-S10, when compared to similar cells derived after the completion of treatment. Natural killer cell activity and interferon-gamma production were associated with nuclear acetylation and phosphorylation status of these histone residues. These findings demonstrate associations among nuclear epigenetic pattern and the immune dysregulation that accompanies psychosocial distress.
Introduction
A diagnosis of breast cancer and the challenge of cancer treatment can be emotionally devastating and are often accompanied by elevations in perceived stress, anxiety and mood disturbance (National Cancer Institute, 1997; Witek-Janusek et al., 2007; Shapiro et al., 2001) . Ample evidence demonstrates that psychosocial distress negatively impacts immune function (Witek-Janusek and Mathews, 2000; Kemeny and Schedlowski, 2007; Glaser and Kiecolt-Glaser, 2005; Segerstrom and Miller, 2004) . The impact on immune function has been demonstrated to include reductions in natural killer cell activity (NKCA) (Biondi, 2001; Kiecolt-Glaser et al., 1987; Witek-Janusek et al., 2007 , 2008 , alteration of cytokine production (Maes et al., 1999; Marshall et al., 1998; Witek-Janusek et al., 2007 , 2008 Esterling et al., 1994) , decreased PBMC proliferative response to mitogens (Kiecolt-Glaser et al., 1991; Andersen et al., 1998 Andersen et al., , 2004 , reductions in specific B-and T-lymphocyte mediated immune responses (Kiecolt-Glaser et al., 1996) , decreased production of interferon (IFN) gamma (WitekJanusek et al., 2007; Glaser et al., 1986; Larson et al., 2000) , and diminished NK cell response to cytokines (Andersen et al., 1998; Fawzy et al., 1990) .
Stress-related impairment of immune function is evident in women with breast cancer. For example, we have previously reported that women undergoing breast cancer diagnosis and treatment exhibit increased anxiety and mood disturbance, accompanied by reduced NKCA and reduced production of IFN gamma (WitekJanusek et al., 2007 (WitekJanusek et al., , 2008 . Others have shown that among women with breast cancer, those who report greater subjective distress after their breast cancer surgery have lower basal and IFN augmented NKCA and reduced T cell proliferative responses to mitogens (Andersen et al., 1998 (Andersen et al., , 2004 . Because NK cells and IFN gamma could potentially contribute to surveillance and destruction of tumor cells (Dighe et al., 1994; Kagi et al., 1994; Kaplan et al., 1998; Smyth et al., 1998 Smyth et al., , 1999 Smyth et al., , 2005 Street et al., 2001; Van Den Broek et al., 1996; Seki et al., 2003; Wallace and Smyth, 2005) , stress-induced immune dysregulation may jeopardize cancer control, especially during vulnerable period such as during and immediately post-treatment (Lutgendorf et al., 2007; Avraham and Ben-Eliyahu, 2007) .
The molecular basis for the effects of psychosocial distress on immune function, relevant to cancer control, is unclear. For early
